AzTrials
AzTrials

Herniated DiscNCT07752199

Effects of Neural Mobilization Combined With Manual Therapy on Infrared Thermography, Inflammatory Markers and Clinical Outcomes in Patients With Lumbar Disc Herniation: A Randomized Controlled Clinical Trial

A study testing Neural Mobilization and Manual Therapy in people with Herniated Disc and Sciatica Due to Intervertebral Disc Disorder, run by Longhua Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this randomized controlled clinical trial is to evaluate whether manual therapy combined with neural mobilization can improve pain, functional impairment, quality of life, inflammatory markers, and infrared thermographic findings in patients with lumbar disc herniation. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Neural Mobilization and Manual Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
72 participants
Where
1 siteChina
Study dates
1 Apr 2025to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • -
  • Participants will be eligible for inclusion if they meet the following criteria:
  • Adults aged 18-65 years. Diagnosis of lumbar disc herniation based on clinical symptoms and imaging findings.
  • Presence of unilateral lumbar radiculopathy. Persistent symptoms despite initial conservative management. Ability to participate in the intervention protocol. Provided written informed consent before study enrollment.

Who cannot join

  • -
  • Participants will be excluded if they meet any of the following criteria:
  • Requirement for surgical intervention for lumbar disc herniation. Serious spinal conditions, including spinal infection, tumor, or fracture. Severe systemic diseases or acute inflammatory conditions. Pregnancy or breastfeeding. Receipt of other interventions that may affect study outcomes during the study period.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

    Shanghai, 200032

Other trials in China

About this study

Official title: Effects of Neural Mobilization Combined With Manual Therapy on Functional Outcomes and Exploratory Infrared Thermographic Changes in Patients With Lumbar Disc Herniation: A Randomized Sham-Controlled Trial

The objective of this randomized controlled clinical trial is to evaluate whether manual therapy combined with neural mobilization can improve pain, functional impairment, quality of life, inflammatory markers, and infrared thermographic findings in patients with lumbar disc herniation. The study subjects consist of 72 patients with lumbar disc herniation (aged 18-65 years, with unilateral lumbar radicular symptoms).

The primary questions it aims to address are:

Read more
  1. In patients with lumbar disc herniation, is manual therapy combined with neural mobilization more effective than manual therapy alone in relieving pain and improving functional impairment?
  2. Can manual therapy combined with neural mobilization improve patients' quality of life, inflammation-related markers (IL-6 and TNF-α), and body temperature changes detected by infrared thermography?

The researchers compared:

  • Experimental group: manual therapy combined with neural mobilization (36 cases)
  • Control group: manual therapy with sham neural mobilization (36 cases) to determine whether adding neural mobilization can provide additional therapeutic effects, including better pain relief, functional recovery, and improvement in related physiological indicators.

Participants will:

  • Receive a 3-week course of treatment, totaling approximately 11 sessions.
  • Undergo standardized manual therapy, including lumbar mobilization and soft tissue therapy, to help relieve pain and improve mobility.
  • Receive additional treatment according to group assignment:
  • The experimental group will receive sciatic nerve mobilization through gentle, controlled leg movements to improve nerve function and reduce nerve sensitivity.
  • The control group will receive lumbar traction therapy to relieve lumbar stress.
  • Be assessed before and after treatment, including pain scores, functional impairment scores (ODI), quality of life surveys (SF-12), infrared thermography examinations, and blood tests for inflammatory markers.
Being tested
Neural Mobilization, Sham Neural Mobilization, Manual Therapy
Medical subject headings
Intervertebral Disc Displacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neural MobilizationBehavioural

    Neural mobilization will be performed using neurodynamics techniques, aiming to improve neural activity and reduce neural mechanosensitivity. The intervention will be conducted over a period of three weeks.

  • Sham Neural MobilizationBehavioural

    The posture and duration of pseudo neural stretching therapy do not produce the expected neurodynamic effects.

  • Manual TherapyBehavioural

    Participants in both groups will receive standardized manual therapy targeting the lumbar spine. The intervention includes lumbar posterior-to-anterior (PA) mobilization and soft tissue mobilization techniques applied to the lumbar paraspinal muscles, gluteal muscles, piriformis, and proximal hamstrings. Manual therapy will be performed within a tolerable range without provoking symptom exacerbation and will be administered every other day for 3 weeks (a total of 11 sessions).

Study groups in NCT07752199
Study groupRoleWhat they receive
Arm 1ExperimentalManual Therapy + Neural Mobilization
Receives: Behavioral: Neural Mobilization; Behavioral: Manual Therapy
Arm 2Sham comparatorManual Therapy + Sham Neural Mobilization
Receives: Behavioral: Sham Neural Mobilization; Behavioral: Manual Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Oswestry Disability Index (ODI) Score

    Measured: Baseline and Week 3 (end of intervention)

Secondary outcomes (4)
  1. Change in Pain Intensity Measured by Visual Analog Scale (VAS)

    Measured: Baseline and Week 3 (end of intervention)

  2. Health-related quality of life (SF-12)

    Measured: Baseline and Week 3

  3. Change in Infrared Thermographic Temperature Parameters

    Measured: Baseline, Week 1, and Week 3

  4. Change in Serum Inflammatory Biomarkers (IL-6 and TNF-α)

    Measured: Baseline and Week 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2026
  2. Study start1 Apr 2025
  3. Primary completion31 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07752199
Sponsor's protocol ID
TJX62023007
Other IDs
ZYYZDKXK-2023059
Status last verified
Aug 2026
First submitted
3 Aug 2026
Last updated
7 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Basson A, Olivier B, Ellis R, Coppieters M, Stewart A, Mudzi W. The Effectiveness of Neural Mobilization for Neuromusculoskeletal Conditions: A Systematic Review and Meta-analysis. J Orthop Sports Phys Ther. 2017 Sep;47(9):593-615. doi: 10.2519/jospt.2017.7117. Epub 2017 Jul 13.

    PubMed 28704626
  • Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. doi: 10.1097/00005650-199603000-00003.

    PubMed 8628042
  • Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952. doi: 10.1097/00007632-200011150-00017.

    PubMed 11074683

Questions about this trial

What is this clinical trial studying?

A study testing Neural Mobilization and Manual Therapy in people with Herniated Disc and Sciatica Due to Intervertebral Disc Disorder, run by Longhua Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Oswestry Disability Index (ODI) Score (time frame: Baseline and Week 3 (end of intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07752199, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in